Investigating the role of SIRT1 in hematopoetic stem cell maintenance

研究 SIRT1 在造血干细胞维持中的作用

基本信息

项目摘要

BACKGROUND: DNA damage is emerging to be a key mediator of age-associated chromatin reorganization, promoting many of the epigenetic changes that correlate with, or mimic, transcriptional deregulation observed with age11. The (histone) deacetylase SIRT1 was shown to be critically involved in several aspects of the DNA damage response as well as in the transcriptional regulation of a variety of key developmental regulators, placing it at the crossroads of DNA damage and epigenetic gene regulation. Consistent with this notion, we have shown previously that SIRT1 redistributes on chromatin from certain promoters and repetitive DNA to sites of DNA breaks, resulting in gene expression changes at ostensibly undamaged genomic loci that are normally regulated by SIRT112. While the resulting chromatin reorganization may at least in part explain age-associated gene deregulation, functional consequences of this process remain to be indentified. To study the role of SIRT1 in epigenomic maintenance, we thus turned to a physiological system that displays a well-established link between DNA damage and epigenomic changes, the hematopoietic stem and precursor cell (HSPC) compartment. Work from Weisman and colleagues showed that various types of DNA damage could severely impair stem cell maintenance, predominantly by reducing self-renewal capacity. Moreover, HSPCs accumulate DNA damage during normal aging and harbor characteristic gene expression changes that may ultimately affect HSPC function. However, it is unclear how DNA damage triggers HSPC exhaustion and if the observed gene expression changes are functionally related. Supporting a role for SIRT1 in the epigenetic (de)regulation of stem cell fate, SIRT1 was shown to be part of a novel polycomb repressive complex, PRC4, which has distinctive chromatin modifying activity and is expressed specifically in undifferentiated cells including embryonic stem cells. Polycomb Group (PcG)-mediated gene regulation is known to play a critical role in HSPC maintenance as loss of the PcG component Bmi-1 ablates HSPC development. Together these observations call for an in depth investigation of SIRT1 function in hematopoietic stem cells. RESULTS AND FUTURE DIRCTIONS: To test the hypothesis that SIRT1 is a critical (epigenetic) mediator of HSPC maintenance and function, we generated a mouse model that allows for the inducible ablation of SIRT1 gene expression in adult animals, thereby avoiding perinatal lethality and/or possible compensation observed in SIRT1-deficient mice. We found that, upon inactivation of SIRT1, the HSPC compartment undergoes an initial phase of proliferative expansion, followed by increased DNA damage and an eventual dramatic depletion in the long-term hematopoietic stem cell compartment. These data demonstrate an important role for SIRT1 in the maintenance of HSPC quiescence as well as the regulation of DNA damage accumulation. We then sought to investigate the mechanism by which SIRT1 mediates these effects, focusing on SIRT1-dependent changes in maintenance of genomic integrity and gene expression. Using microarray analysis in sorted HSPCs, we found that, out of a group of 11 Gene Ontology annotated genes associated with definitive hematopoiesis, a single candidate gene was strongly upregulated in the absence of SIRT1. This gene was previously shown to promote HSPC expansion and has further been linked to acute myelogenous leukemia (AML), a cancer derived from aberrantly proliferating hematopoietic progenitor cells. Using chromatin immunoprecipitation (ChIP) we found that Sirt1 binds to the this gene at the DNA level and that Sirt1 enrichment is correlated with the polycomb-group (PcG) repressive mark H3K27 (3Me), provinding the first evidence that Sirt1 may modulate PcG associated developmental genes to promote the maintenance of stem cells. Future work will dissect the molecular basis for this observation using depletion of this SIRT1 target gene by RNAi as well as a detailed analysis of theo role of PRC4 in this process. To address the functional consequences of HSPC expansion/exhaustion associated with loss of SIRT1, we are currently performing both competitive and (serial) non-competitive bone marrow reconstitution experiments. IMPLICATIONS: Our preliminary data suggest an important role for SIRT1 in HSPC maintenance, where loss of SIRT1 promotes HSPC expansion and eventually exhaustion corroborating the importance of SIRT1 as a regulator of developmental programs. The tight regulation of HSPC proliferation is a critical aspect of mammalian development and does not only affect the generation of normal hematopoietic cells but is closely linked to tumors of the hematopoietic lineage. Both acute and chronic myeloid leukemia arise from aberrant proliferation of HSPCs and a better understanding of the underlying regulators is critical to design targeted therapy.

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Philipp Oberdoerffer其他文献

Philipp Oberdoerffer的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Philipp Oberdoerffer', 18)}}的其他基金

Investigating the role of DNA breaks in mammalian aging
研究 DNA 断裂在哺乳动物衰老中的作用
  • 批准号:
    8553080
  • 财政年份:
  • 资助金额:
    $ 32.11万
  • 项目类别:
Investigating the link between DNA damage, chromatin and nuclear dysfunction
研究 DNA 损伤、染色质和核功能障碍之间的联系
  • 批准号:
    9556510
  • 财政年份:
  • 资助金额:
    $ 32.11万
  • 项目类别:
RNAi screen for chromatin modifiers in DNA repair and aging
RNAi 筛选 DNA 修复和衰老中的染色质修饰剂
  • 批准号:
    8938037
  • 财政年份:
  • 资助金额:
    $ 32.11万
  • 项目类别:
RNAi screen for chromatin modifiers in DNA repair and aging
RNAi 筛选 DNA 修复和衰老中的染色质修饰剂
  • 批准号:
    8349443
  • 财政年份:
  • 资助金额:
    $ 32.11万
  • 项目类别:
Investigating the role of SIRT1 in hematopoetic stem cell maintenance
研究 SIRT1 在造血干细胞维持中的作用
  • 批准号:
    8553137
  • 财政年份:
  • 资助金额:
    $ 32.11万
  • 项目类别:
RNAi screen for chromatin modifiers in DNA repair and aging
RNAi 筛选 DNA 修复和衰老中的染色质修饰剂
  • 批准号:
    8763431
  • 财政年份:
  • 资助金额:
    $ 32.11万
  • 项目类别:
Investigating the role of DNA breaks in mammalian aging
研究 DNA 断裂在哺乳动物衰老中的作用
  • 批准号:
    8938038
  • 财政年份:
  • 资助金额:
    $ 32.11万
  • 项目类别:
Investigating the role of DNA breaks in mammalian aging
研究 DNA 断裂在哺乳动物衰老中的作用
  • 批准号:
    8763432
  • 财政年份:
  • 资助金额:
    $ 32.11万
  • 项目类别:
Investigating the link between DNA damage, chromatin and nuclear dysfunction
研究 DNA 损伤、染色质和核功能障碍之间的联系
  • 批准号:
    10014589
  • 财政年份:
  • 资助金额:
    $ 32.11万
  • 项目类别:
The impact of malignant transformation on DNA double-strand break repair.
恶性转化对DNA双链断裂修复的影响。
  • 批准号:
    8938189
  • 财政年份:
  • 资助金额:
    $ 32.11万
  • 项目类别:

相似国自然基金

阿魏酸基天然抗氧化抗炎纳米药物用于急性肾损伤诊疗一体化研究
  • 批准号:
    82302281
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
SGO2/MAD2互作调控肝祖细胞的细胞周期再进入影响急性肝衰竭肝再生的机制研究
  • 批准号:
    82300697
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
基于hemin-MOFs的急性心肌梗塞标志物负背景光电化学-比色双模分析
  • 批准号:
    22304039
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
RNA甲基转移酶NSUN2介导SCD1 mRNA m5C修饰调控急性髓系白血病细胞铁死亡的机制研究
  • 批准号:
    82300173
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
基于IRF5/MYD88信号通路调控巨噬细胞M1极化探讨针刀刺营治疗急性扁桃体炎的机制研究
  • 批准号:
    82360957
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    地区科学基金项目

相似海外基金

Role of heat shock transcription factors (HSFs) in hematological malignancies
热休克转录因子(HSF)在血液恶性肿瘤中的作用
  • 批准号:
    10568307
  • 财政年份:
    2023
  • 资助金额:
    $ 32.11万
  • 项目类别:
Multi-functional cellular therapies to overcome tumor heterogeneity and limit toxicity in acute myeloid leukemia
多功能细胞疗法克服肿瘤异质性并限制急性髓系白血病的毒性
  • 批准号:
    10679763
  • 财政年份:
    2023
  • 资助金额:
    $ 32.11万
  • 项目类别:
Targeting leukemic stem cells in acute myeloid leukemia
靶向治疗急性髓系白血病的白血病干细胞
  • 批准号:
    10561291
  • 财政年份:
    2023
  • 资助金额:
    $ 32.11万
  • 项目类别:
Determining the Microenvironmental Contribution to Acute Myeloid Leukemia Chemoresistance
确定微环境对急性髓系白血病化疗耐药性的影响
  • 批准号:
    10602784
  • 财政年份:
    2023
  • 资助金额:
    $ 32.11万
  • 项目类别:
Targeting mitochondrial dynamics in drug-resistant acute myeloid leukemia
靶向耐药急性髓系白血病的线粒体动力学
  • 批准号:
    10751235
  • 财政年份:
    2023
  • 资助金额:
    $ 32.11万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了